Department of Biotechnology, Cancer Research UK sign MoU for India-UK Cancer Research Initiative
The India-UK Cancer Research Initiative will focus on affordable approaches to cancer. Both CRUK and DBT will invest 5 million pounds each in this pilot project and will seek further investment from other potential funding partners.
The Department of Biotechnology (DBT) of India and Cancer Research UK on November 14, 2018 signed a Memorandum of Understanding (MoU) for the India-UK India-UK Cancer Research Initiative.
The India-UK Cancer Research Initiative is a collaborative 5-year bilateral research initiative by the Department of Biotechnology under Union Ministry of Science and Technology and Cancer Research UK (CRUK).
The Initiative was launched at the Inaugural Researchers’ Summit, which was held in New Delhi from November 14 to November 16, 2018.
The signing of MoU comes as a follow up of the joint statement issued by the Prime Ministers of India and United Kingdom during the visit of Prime Minister Narendra Modi to UK on April 18, 2018.
At that time, India’s Department of Biotechnology (DBT) and Cancer Research UK proposed to launch a 10 million pounds bilateral research initiative which will focus on low cost approaches to cancer treatment.
India-UK Cancer Research Initiative
• The India-UK Cancer Research Initiative will focus on affordable approaches to cancer. Both CRUK and DBT will invest 5 million pounds each in this pilot project and will seek further investment from other potential funding partners.
• The initiative will identify a core set of research challenges that address issues of affordability, prevention and care of cancer by bringing together leading Indian and UK experts.
• The initiative will provide funding to develop new research alliances and undertake impactful research to enable significant progress against cancer outcomes.
• The India-UK Cancer Research Initiative will provide a catalysing platform for scientists and researchers in the UK and India to co-create solutions for affordable cancer care that improve cancer outcomes around the globe.
Chair and Co-chair of the India-UK Cancer Research Initiative
Professor David Hunter of the University of Oxford and Dr CS Pramesh of the Tata Memorial Hospital will serve respectively as Chair and Co-chair of the India-UK Cancer Research Initiative’s Advisory Panel.
The research phases of the India-UK Cancer Research Initiative will be overseen by a board of advisors comprising five cancer experts each from India and UK.
• The India-UK Cancer Research Initiative provides an opportunity to tackle the global epidemic of cancer by opening new pathways for international knowledge exchange and research base.
• The research outcomes of this initiative will aid cancer prevention, control and management in the long term.
• This initiative is a testament to the emerging consensus that solutions to affordable cancer care lie in building strategic and evidence-based research partnerships that benefit the global cancer community.